Bilayer Therapeutics is a development-stage company co-founded in 2020 by a team of world-renowned drug development and delivery experts and gastroenterologists to stimulate the body’s innate mechanisms for regulating constipation. Led by BL-010, a proprietary bilayer tablet comprised of a naturally occurring bile acid (chenodeoxycholate or CDC) , the company is developing innovative treatments for Chronic Idiopathic Constipation, Irritable Bowel Syndrome with Constipation and other conditions of the colon such as IBD (ulcerative cholitis, Crohn's disease), and diabetes / obesity / metabolic disorders.